about
Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease.Fitness Barriers Limit Reversion of a Proofreading-Deficient CoronavirusSmall-Molecule Antiviral β-d--Hydroxycytidine Inhibits a Proofreading-Intact Coronavirus with a High Genetic Barrier to ResistanceAn orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 and multiple endemic, epidemic and bat coronavirusAn orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in miceThe coronavirus proofreading exoribonuclease mediates extensive viral recombinationRemdesivir potently inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in miceFitness barriers limit reversion of a proofreading-deficient coronavirus
P50
Q53704198-620EEDC9-BB7B-4013-8F33-C383C716ED9EQ84315481-45517245-0D0D-44DA-9FC0-0FF9C6DD67A5Q84315917-4E94820C-8E74-4897-843F-91A1B33983C6Q88978122-859C04AD-86DA-4421-BCDE-726C7B37B1E1Q91610063-2B4027D8-4E55-47BA-ACFD-60F92C1BCA8DQ91956371-D693FC64-321B-41B6-8C64-C998EE4A5AF6Q95602244-86727037-8972-4E3A-8031-ED5CD6DA18DBQ95630778-930FB43B-1F62-4074-8660-749DEA25E6B3
P50
description
virologa
@it
virologist
@en
viróloga
@es
name
Maria L. Agostini
@es
Maria L. Agostini
@nl
Maria Luisa Agostini
@en
Maria Luisa Agostini
@fr
Maria Luisa Agostini
@it
Maria Luisa Agostini
@sc
type
label
Maria L. Agostini
@es
Maria L. Agostini
@nl
Maria Luisa Agostini
@en
Maria Luisa Agostini
@fr
Maria Luisa Agostini
@it
Maria Luisa Agostini
@sc
altLabel
Maria L. Agostini
@it
prefLabel
Maria L. Agostini
@es
Maria L. Agostini
@nl
Maria Luisa Agostini
@en
Maria Luisa Agostini
@fr
Maria Luisa Agostini
@it
Maria Luisa Agostini
@sc